Loading...
•
Sep 30, 2020
Balchem Q3 2020 Earnings Report
Balchem reported record third-quarter sales and increased net earnings.
Key Takeaways
Balchem Corporation reported record third quarter net sales of $175.1 million and net earnings of $21.6 million. The company's adjusted EBITDA reached an all-time record of $44.4 million.
Net sales increased by 10.4% to $175.1 million compared to the prior year quarter, driven by growth in Human Nutrition & Health and Animal Nutrition & Health segments.
GAAP net earnings increased by 4.3% to $21.6 million, resulting in GAAP earnings per share of $0.66.
Adjusted net earnings increased by 2.3% to $26.9 million, resulting in adjusted earnings per share of $0.83.
Adjusted EBITDA increased by 10.1% to $44.4 million from the prior year.
Balchem
Balchem
Balchem Revenue by Segment
Revenue by Segment
Human Nutrition & Health Revenue
CapyFin.comAnimal Nutrition & Health Revenue
CapyFin.comSpecialty Products Revenue
CapyFin.com Forward Guidance
The company did not provide specific forward guidance in the provided document.
Revenue & Expenses
Visualization of income flow from segment revenue to net income